239 related articles for article (PubMed ID: 28704452)
1. Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome.
Engel M; Endesfelder D; Schloter-Hai B; Kublik S; Granitsiotis MS; Boschetto P; Stendardo M; Barta I; Dome B; Deleuze JF; Boland A; Müller-Quernheim J; Prasse A; Welte T; Hohlfeld J; Subramanian D; Parr D; Gut IG; Greulich T; Koczulla AR; Nowinski A; Gorecka D; Singh D; Gupta S; Brightling CE; Hoffmann H; Frankenberger M; Hofer TP; Burggraf D; Heiss-Neumann M; Ziegler-Heitbrock L; Schloter M; Zu Castell W
PLoS One; 2017; 12(7):e0180859. PubMed ID: 28704452
[TBL] [Abstract][Full Text] [Related]
2. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
[TBL] [Abstract][Full Text] [Related]
3. The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease.
Pragman AA; Lyu T; Baller JA; Gould TJ; Kelly RF; Reilly CS; Isaacson RE; Wendt CH
Microbiome; 2018 Jan; 6(1):7. PubMed ID: 29316977
[TBL] [Abstract][Full Text] [Related]
4. Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.
Lee SW; Kuan CS; Wu LS; Weng JT
PLoS One; 2016; 11(7):e0159066. PubMed ID: 27428540
[TBL] [Abstract][Full Text] [Related]
5. Signatures within the esophageal microbiome are associated with host genetics, age, and disease.
Deshpande NP; Riordan SM; Castaño-Rodríguez N; Wilkins MR; Kaakoush NO
Microbiome; 2018 Dec; 6(1):227. PubMed ID: 30558669
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation induces a microbiota shift in sputa of COPD patients.
Jubinville E; Veillette M; Milot J; Maltais F; Comeau AM; Levesque RC; Duchaine C
PLoS One; 2018; 13(3):e0194355. PubMed ID: 29579057
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the lung microbiome in the "healthy" smoker and in COPD.
Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB
PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.
Bassis CM; Erb-Downward JR; Dickson RP; Freeman CM; Schmidt TM; Young VB; Beck JM; Curtis JL; Huffnagle GB
mBio; 2015 Mar; 6(2):e00037. PubMed ID: 25736890
[TBL] [Abstract][Full Text] [Related]
9. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
[TBL] [Abstract][Full Text] [Related]
10. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
F1000Res; 2023; 12():528. PubMed ID: 37928173
[No Abstract] [Full Text] [Related]
11. Bacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid.
Naito K; Yamasaki K; Yatera K; Akata K; Noguchi S; Kawanami T; Fukuda K; Kido T; Ishimoto H; Mukae H
Int J Chron Obstruct Pulmon Dis; 2017; 12():2111-2120. PubMed ID: 28790814
[TBL] [Abstract][Full Text] [Related]
12. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
14. The bronchial epithelial cell bacterial microbiome and host response in patients infected with human immunodeficiency virus.
Sze MA; Xu S; Leung JM; Vucic EA; Shaipanich T; Moghadam A; Harris M; Guillemi S; Sinha S; Nislow C; Murphy D; Hague C; Leipsic J; Lam S; Lam W; Montaner JS; Sin DD; Man SF
BMC Pulm Med; 2016 Nov; 16(1):142. PubMed ID: 27829448
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing.
Zakharkina T; Heinzel E; Koczulla RA; Greulich T; Rentz K; Pauling JK; Baumbach J; Herrmann M; Grünewald C; Dienemann H; von Müller L; Bals R
PLoS One; 2013; 8(7):e68302. PubMed ID: 23874580
[TBL] [Abstract][Full Text] [Related]
16. Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice.
Hilty M; Wüthrich TM; Godel A; Adelfio R; Aebi S; Burgener SS; Illgen-Wilcke B; Benarafa C
Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33295863
[TBL] [Abstract][Full Text] [Related]
17. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
[TBL] [Abstract][Full Text] [Related]
18. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
[TBL] [Abstract][Full Text] [Related]
19. The lung microbiome in moderate and severe chronic obstructive pulmonary disease.
Pragman AA; Kim HB; Reilly CS; Wendt C; Isaacson RE
PLoS One; 2012; 7(10):e47305. PubMed ID: 23071781
[TBL] [Abstract][Full Text] [Related]
20. Application of a neutral community model to assess structuring of the human lung microbiome.
Venkataraman A; Bassis CM; Beck JM; Young VB; Curtis JL; Huffnagle GB; Schmidt TM
mBio; 2015 Jan; 6(1):. PubMed ID: 25604788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
